Also specifies the importation of such products into the country without identification. The corresponding decree comes into force from 1 July and will run until January 2021.
with the Exception of drugs for medical use, intended for patients with hemophilia, cystic fibrosis, pituitary dwarfism, Gaucher disease, malignant neoplasms of lymphoid, hematopoietic and related tissue, multiple sclerosis, and persons after transplantation of bodies and fabrics.
the Control of production imported on territory of Russia of medicines, as well as putting them into circulation will be carried out on the basis of the approval of the Federal service for supervision in the sphere of health. Approval will be issued for 45 days.
